Remarkably, both the expression of p53 (Figure 3D) and p21 (Figure 3E) resulted in significantly increased SOD1-G93A mice in all three areas, highlighting a deregulation of this pathway in the ALS symptomatic animal model. This evidence concerns the gene TP53 and amyotrophic lateral sclerosis.